Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
With the release of two new classes of antiretrovirals last fall, most care providers needed to quickly get back on the learning curve to master both drugs simultaneously. Fortunately, the new integrase inhibitor raltegravir (Isentress) has one standard dosage for all adults: one pill twice a day with or without food. It has no drug interactions and should work in any patient with HIV. However, it takes a little more study to use the other newly approved drug, maraviroc (Selzentry). When it was discovered that people are essentially resistant to HIV if they lack the CCR5 receptor on the surface of their CD4 cells, the hunt was on to find a CCR blocker. Maraviroc is the first of this class. But only about 70% to 80% of people with HIV have an R5 virus that uses CCR5 to gain access to the CD4 cell. About 2% to 5% have an X4 virus that uses another receptor, CXCR4. The remaining 20% to 30% have a virus population that is a mixture of R5 and X4. The first step in using maraviroc is to test to see if a patient has R5 virus. This test is currently available through only one laboratory. It takes two to three weeks to get results and requires a viral load of at least 1,000. The test is also expensive, but at the moment it seems to be covered by insurance. Next, the dosage may need to be raised or lower based on what other drugs the patient is taking, since maraviroc is processed through a common liver pathway called CYP 3A4. This is the pathway used by most protease inhibitors and blocked by ritonavir. Hence, the maraviroc dosage is cut in half when used in combination with a ritonavir-boosted protease inhibitor. Alternatively maraviroc must be double when used with efavirenz, which up-regulates CYP 3A4 activity. Then there are exceptions like nevirapine or boosted tipranovir, both of which cause no change in maraviroc levels. And when both a boosted PI and efavirenz are used, the boosted-PI affect wins and the dosage is halved. Confused and concerned? Don't be. The maraviroc prescribing literature has a clear chart to follow. But don't forget to review the maraviroc dosage whenever changes are made in a treatment regimen. At least it is as easy to take as raltegravir: one pill twice a day with or without food. Bowers is an HIV specialist and board-certified physician in family practice, and he is a senior partner with Pacific Oaks Medical Group, one of the largest U.S. practices devoted to HIV care, in Beverly Hills, Calif.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
The Most Amazing HIV Allies & Advocates of 2023
November 03 2023 12:51 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
This OnlyFans Star Is Trying to Raise $100K to Fight HIV
December 26 2023 3:05 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
The naked Black body takes center stage in this HIV campaign
January 03 2024 1:07 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Mr. Gay World wants to make sure you're OK
January 02 2024 4:56 PM
Plus: Featured Video
Latest Stories
The government failed on mpox. Ritchie Torres's new bill addresses that
April 18 2024 1:21 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Our May/June issue of Plus is here!
April 17 2024 12:00 PM
Giselle Byrd is taking center stage — and helping others do the same
April 10 2024 2:24 PM
Discover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 3:57 PM
HIV-positive Air Force, Navy servicemembers victorious in lawsuit
April 09 2024 3:02 PM
Unlocking a new level of beauty with Dr Botanicals' ethical skincare line
April 08 2024 3:40 PM
Unleash your wild side with The Pride Store’s beginner’s guide to kink
April 08 2024 3:35 PM
Why are mpox cases in the U.S. on the rise again?
April 08 2024 1:30 PM
Happy national foreskin day!
April 04 2024 1:45 PM
Adult entertainment icons Derek Kage & Cody Silver lead fight for free speech
April 03 2024 3:06 PM
LGBTQ+ patients twice as likely to face discrimination: survey
April 02 2024 4:57 PM
Spring into The Pride Store’s top new arrivals for April
April 02 2024 4:39 PM
Nashville PD Must Pay HIV-Positive Man Denied a Job
April 01 2024 6:22 PM
Common has a message on how to foster self-love
March 29 2024 7:33 PM
Listen to Dr. Levine: Take syphilis seriously
March 28 2024 6:40 PM
Breaking boundaries in gender-free fashion with Stuzo Clothing
March 27 2024 2:15 PM